Cleared Traditional

K111498 - FATHOM (TM) 14 STEERABLE GUIDEWIRE

K111498 is the FDA 510(k) clearance for FATHOM (TM) 14 STEERABLE GUIDEWIRE by Boston Scientific Corp. It is a Class 2 Cardiovascular device (product code DQX) cleared through the Traditional 510(k) pathway after a 30-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2011
Decision
30d
Days
Class 2
Risk

K111498 is an FDA 510(k) clearance for the FATHOM (TM) 14 STEERABLE GUIDEWIRE. Classified as Wire, Guide, Catheter (product code DQX), Class II - Special Controls.

Submitted by Boston Scientific Corp (Maple Grove, US). The FDA issued a Cleared decision on June 30, 2011 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Boston Scientific Corp devices

Submission Details

510(k) Number K111498 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 31, 2011
Decision Date June 30, 2011
Days to Decision 30 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
95d faster than avg
Panel avg: 125d · This submission: 30d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQX Wire, Guide, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQX Wire, Guide, Catheter

All 450
Devices cleared under the same product code (DQX) and FDA review panel - the closest regulatory comparables to K111498.
ASAHI ULTIMATEBROS 3 PTCA GUIDE WIRE
K101986 · Asahi Intecc Co., Ltd. · Sep 2011
PRIMEWIRE PRESTIGE PLUS
K111395 · Volcano Corporation · Aug 2011
FATHOM 16 STEERABLE GUIDEWIRE MODEL M001509XXX
K111485 · Boston Scientific Corporation · Jun 2011
ACUITY WHISPER VIEW GUIDE WIRES
K110479 · Boston Scientific Corp · Apr 2011
ASAHI GUIDE WIRE EXTENSION 165CM
K101985 · Asahi Intecc Co., Ltd. · Mar 2011
APPROACH PRO ST WIRE GUIDE
K110163 · Cook Incorporated · Feb 2011